Clinical Trials in Ohio

Showing 16701-16720 of 20,938 trials

LiDCO Monitor Study

NCT01567371

This is a study to validate the utility and accuracy of the non-invasive device (LiDCOrapid monitor) during a period of phlebotomy and graded blood loss in patients who are having cardiac surgery.

Cardiac Surgery

Nationwide Children's Hospital30 participantsStarted Mar 2012

Columbus, Ohio, United States

COMPLETEDPhase 378 miles

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

NCT00248170

Eligible patients will be post-menopausal hormone receptor- and lymph node-positive females who recently underwent primary surgery for breast cancer. Patients will be randomized to letrozole (2.5 mg per day for 5 years) vs anastrozole (1 mg per day for 5 years). Follow up will occur for 5 years after the completion of enrollment for survival and disease status updates.

Breast Cancer

Novartis Pharmaceuticals4,172 participantsStarted Dec 2005

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Flagstaff, Arizona, United States +256 more locations

LiDCO Monitor Study

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

Find Trials by Condition in Ohio

Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Dose Comparison Study of Menactra® in US Children

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

AMG 595 First-in-Human in Recurrent Gliomas

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator